SCHEMBL5155652

SCHEMBL5155652

[CH2]C#CC(O)(CC)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL395580 0.81 TSHR (0.31)
SCHEMBL5153428 0.78 FDPS (0.32)
SCHEMBL8053513 0.73
SCHEMBL468009 0.72
SCHEMBL12778802 0.71 TSHR (0.32)
SCHEMBL13818441 0.71 TSHR (0.32)
SCHEMBL3383426 0.71
SCHEMBL1169619 0.69
SCHEMBL7159136 0.69
SCHEMBL6136603 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103300-B1 ULTRAVIOLET IRRADIATION APPARATUS FOR PHOTOCHEMICAL REACTION AND METHOD FOR PREPARING VITAMIN D DERIVATIVE USING THE SAME CHUGAI PHARMACEUTICAL CO LTD (JP) 2007-01-03 EP disclosed
US-6902654-B2 Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-06-07 US disclosed
US-20040108198-A1 Ultraviolet irradiation apparatus for photochemical reaction and preparation process of vitamin D derivative making use of the same CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2004-06-10 US disclosed
EP-0972762-B1 Novel structural analogues of vitamin D THERAMEX (MC) 2003-10-01 EP disclosed
EP-0947504-B1 16-ENE-VITAMIN D DERIVATIVES CHUGAI PHARMACEUTICAL CO LTD (JP) 2003-09-03 EP disclosed
US-6555699-B2 Antitumor and antirheumatic agents, high binding affinity CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-29 US disclosed
US-6548715-B1 Which lacks the combined presence of the trans-fused ring; increased therapeutic potential; for cell proliferation; veterinary medicine LABORATOIRE THERAMEX S.A. (MC) 2003-04-15 US disclosed
US-20020193616-A1 16-ENE-VITAMIN D DERIVATIVES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-12-19 US disclosed
US-6433200-B1 ANTITUMOR AND ANTIRHEUMATIC AGENTS, HIGH BINDING AFINITY TO VITAMIN D RECEPTORS AND WEAK HYPERCALCEMIC ACTIVITY CHUGEI SEIYAKU KABUSHIKI KAISHA (JP) 2002-08-13 US disclosed
US-20020032340-A1 16-ene-vitamin D derivatives CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-03-14 US disclosed
US-6184398-B1 ANTITUMOR AGENTS AND TREATMENT OF RHEUMATIC CONDITIONS; HIGH BINDING ABILITY TO VITAMIN D RECEPTORS AND WEAK HYPERCALCEMIC ACTIVITY; E.G.,1,3-DIHYDROXY-20-3-HYDROXY-3-METHYLBUTYLTHIO)-9,10-SECOPREGNA -5,7,10(19),16-TETRAENE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2001-02-06 US disclosed
EP-1021401-A1 CALCITRIOL DERIVATIVES AND THEIR USES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2000-07-26 EP disclosed
EP-0707566-B1 NOVEL STRUCTURAL ANALOGUES OF VITAMIN D THERAMEX (MC) 2000-04-12 EP disclosed
US-6017907-A Structural analogues of vitamin D LABORATOIRE THERAMEX S.A. (MC) 2000-01-25 US disclosed
EP-0972762-A2 Novel structural analogues of vitamin D LABORATOIRE THERAMEX (MC) 2000-01-19 EP disclosed
US-5976784-A DERIVATIVE WITH IN VIVO HYDROLYZABLE HYDROCARBYLOXYCARBONYL OR ACYL GROUPS FOR GRADUAL IN VIVO RELEASE OF BIOLOGICALLY ACTIVE VITAMIN D COMPOUND; TREATMENT OF OSTEOPOROSIS, PSORIASIS, RENAL OSTEODYSTROPHY, GLANDULAR AND BONE DISORDERS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1999-11-02 US disclosed
EP-0947504-A1 16-ENE-VITAMIN D DERIVATIVES Chugai Seiyaku Kabushiki Kaisha (JP) 1999-10-06 EP disclosed
WO-1997011053-A1 CALCITRIOL DERIVATIVES AND THEIR USES WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1997-03-27 WO disclosed
EP-0707566-A1 NOVEL STRUCTURAL ANALOGUES OF VITAMIN D LABORATOIRE THERAMEX S.A. (MC) 1996-04-24 EP disclosed
WO-1995001960-A1 NOVEL STRUCTURAL ANALOGUES OF VITAMIN D LABORATOIRE THERAMEX S.A. (MC) 1995-01-19 WO disclosed